Similar dynamics of intraapheresis autologous CD34+ recruitment and collection efficiency in patients undergoing mobilization with or without plerixafor.
Phase of Trial: Phase IV
Latest Information Update: 23 Dec 2015
At a glance
- Drugs Plerixafor (Primary) ; Growth factors
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 23 Dec 2015 New trial record